146 related articles for article (PubMed ID: 6439114)
1. Bactericidal activity of ceftazidime in serum compared with that of ticarcillin combined with amikacin.
Standiford HC; Drusano GL; Fitzpatrick B; Tatem B; Schimpff SC
Antimicrob Agents Chemother; 1984 Sep; 26(3):339-42. PubMed ID: 6439114
[TBL] [Abstract][Full Text] [Related]
2. Serum bactericidal activity and killing rate for volunteers receiving imipenem, imipenem plus amikacin, and ceftazidime plus amikacin against Pseudomonas aeruginosa.
Van der Auwera P; Klastersky J; Lagast H; Husson M
Antimicrob Agents Chemother; 1986 Jul; 30(1):122-6. PubMed ID: 3092729
[TBL] [Abstract][Full Text] [Related]
3. Serum bactericidal activity as a therapeutic guide in severely granulocytopenic patients with gram-negative septicemia.
Martino P; Venditti M; Valente B; Mandelli F; Serra P
Eur J Cancer Clin Oncol; 1985 Apr; 21(4):439-45. PubMed ID: 3891360
[TBL] [Abstract][Full Text] [Related]
4. Serum bactericidal activity of mezlocillin, ceftazidime, mezlocillin/ceftazidime and mezlocillin/amikacin against Klebsiella pneumoniae and Pseudomonas aeruginosa.
Van Laethem Y; Klastersky J
Eur J Clin Microbiol; 1986 Feb; 5(1):110-4. PubMed ID: 3084239
[TBL] [Abstract][Full Text] [Related]
5. Empiric antibiotic therapy for suspected infection in granulocytopenic cancer patients: a comparison between the combination of moxalactam plus amikacin and ticarcillin plus amikacin.
De Jongh CA; Wade JC; Schimpff SC; Newman KA; Finley RS; Salvatore PC; Moody MR; Standiford HC; Fortner CL; Wiernik PH
Am J Med; 1982 Jul; 73(1):89-96. PubMed ID: 6211981
[TBL] [Abstract][Full Text] [Related]
6. Bactericidal activity and killing rate of serum from volunteers receiving pefloxacin alone or in combination with amikacin.
Van der Auwera P; Klastersky J; Lieppe S; Husson M; Lauzon D; Lopez AP
Antimicrob Agents Chemother; 1986 Feb; 29(2):230-4. PubMed ID: 3087276
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of single-agent therapy with azlocillin, ticarcillin, and amikacin and beta-lactam/amikacin combinations for treatment of Pseudomonas aeruginosa bacteremia in granulocytopenic rats.
Johnson DE; Thompson B
Am J Med; 1986 May; 80(5C):53-8. PubMed ID: 3636060
[TBL] [Abstract][Full Text] [Related]
8. Piperacillin or ticarcillin plus amikacin. A double-blind prospective comparison of empiric antibiotic therapy for febrile granulocytopenic cancer patients.
Wade JC; Schimpff SC; Newman KA; Fortner CL; Standiford HC; Wiernik PH
Am J Med; 1981 Dec; 71(6):983-90. PubMed ID: 6459027
[TBL] [Abstract][Full Text] [Related]
9. Serum bactericidal activity of ceftazidime and cefoperazone alone or in combination with amikacin against Pseudomonas aeruginosa and Klebsiella pneumoniae.
Van Laethem Y; Lagast H; Klastersky J
Antimicrob Agents Chemother; 1983 Mar; 23(3):435-9. PubMed ID: 6221694
[TBL] [Abstract][Full Text] [Related]
10. Pseudomonas peritonitis in neutropenic rats treated with amikacin, ceftazidime and ticarcillin, alone and in combination.
Shyu WC; Nightingale CH; Quintiliani R
J Antimicrob Chemother; 1987 Jun; 19(6):807-14. PubMed ID: 3112102
[TBL] [Abstract][Full Text] [Related]
11. [Synergistic activity between ticarcillin, azlocillin, cefsulodin, ceftazidime and tobramycin or amikacin against Pseudomonas aeruginosa (author's transl)].
Petit JC; Richard G; Burghoffer B; Daguet GL
Pathol Biol (Paris); 1982 Jun; 30(6):426-31. PubMed ID: 6810286
[TBL] [Abstract][Full Text] [Related]
12. Amikacin + ceftazidime therapy of experimental right-sided Pseudomonas aeruginosa endocarditis in rabbits.
Bayer AS; Lam K; Norman D; Kim KS; Morrison JO
Chemotherapy; 1985; 31(5):351-61. PubMed ID: 3931992
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of amikacin and ceftazidime in experimental aortic valve endocarditis due to Pseudomonas aeruginosa.
Bayer AS; Norman D; Kim KS
Antimicrob Agents Chemother; 1985 Dec; 28(6):781-5. PubMed ID: 3909954
[TBL] [Abstract][Full Text] [Related]
14. Empirical antimicrobial therapy with Timentin plus amikacin in febrile granulocytopenic cancer patients.
Meunier F; Snoeck R; Lagast H; Woussen F; Klastersky J
J Antimicrob Chemother; 1986 May; 17 Suppl C():195-201. PubMed ID: 3636334
[TBL] [Abstract][Full Text] [Related]
15. Comparative study of the serum bactericidal activity of cefoperazone alone and in combination with amikacin or mezlocillin against gram-negative bacilli and Staphylococcus aureus.
Lagast H; Klastersky J; Standiford H; Viollier A
Infection; 1984; 12(3):190-3. PubMed ID: 6432702
[TBL] [Abstract][Full Text] [Related]
16. [Value of bactericidal curves in the optimal selection of a beta-lactam-aminoglycoside combination on Pseudomonas aeruginosa. In vitro study of 40 strains of Pseudomonas aeruginosa isolated in pediatric intensive care units].
Lambert-Zechovsky N; Bingen E; Guihaire E; Nancy C; Mercier JC; Beaufils F
Presse Med; 1986 Dec; 15(46):2309-12. PubMed ID: 2949273
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of bacterial infection in acute leukemia, quadruple chemotherapy using CFX, AMK, TIPC and LCM (author's transl)].
Yamaguchi H; Ichimaru M
Jpn J Antibiot; 1980 Nov; 33(11):1215-22. PubMed ID: 7241796
[No Abstract] [Full Text] [Related]
18. In vitro evaluation of N-formimidoyl thienamycin (MK0787) combined with amikacin against gram-negative bacilli and Staphylococcus aureus.
Díez Enciso M; Mateos Lindemann M; Gutiérrez Altés A
Antimicrob Agents Chemother; 1982 Dec; 22(6):1064-6. PubMed ID: 6818899
[TBL] [Abstract][Full Text] [Related]
19. Bactericidal efficacy of Sch 20569 and amikacin against gentamicin-sensitive and -resistant organisms.
Rahal JJ; Simberkoff MS; Kagan K; Moldover NH
Antimicrob Agents Chemother; 1976 Apr; 9(4):595-9. PubMed ID: 817661
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of amikacin and ticarcillin as empiric therapy in febrile neutropenic children with cancer.
Faden HS; Deshpande GN; Grossi M; Surgalla M; Ettinger LJ; Freeman AI
Med Pediatr Oncol; 1981; 9(5):501-9. PubMed ID: 7300805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
